Home › Traumatic Brain Injury › NCT06725108

Hemodynamic ABI Monitor

Non-invasive Continuous Hemodynamic Monitoring in Acute Brain Injury

Who can join

Ages 18 to 80 · All sexes

Inclusion:

Patients who are:

* Admitted to the University of Chicago Medical Center Neurocritical Care Unit
* Adults between 18 years and 80
* Admitted with Traumatic brain injury blunt and penetrating or nontraumatic intracerebral hemorrhage
* post-resuscitation Glasgow Coma Scale (GCS) \<9

Exclusion:

Patients who were:

* Pre-existing heart failure
* Moribund or neurological exam suggesting imminent brain death (bilateral, fixed and dilated pupils) on admission
* Major polytrauma or admitted to the surgical trauma critical care service
* Prisoner

About the study

The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data.

Participants already taking intervention A as part of their regular medical care and the investigators will follow up with participants 6 months after discharging the hospital.

Sponsor: University of Chicago · Participants: 50 · Started: Dec 6, 2024

Contact the study team

• Farima Fakhri, MD · Phone: 3126102482

Official record on ClinicalTrials.gov — NCT06725108

Locations in the U.S.

Conditions

• Traumatic Brain Injury
• Cerebral Hemorrhage
• Brain Injuries

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.